Normal Variants and Pitfalls of 18F_FDG PET/CT in Pediatric Oncology
Launched by ASSIUT UNIVERSITY · Sep 22, 2024
Trial Information
Current as of June 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how 18F-FDG PET/CT scans can sometimes show normal differences in children and teens with cancer, as well as some common mistakes in reading the results. The goal is to help doctors better understand these scans so they can make more accurate decisions about a patient's care.
The trial is open to all pediatric cancer patients who are referred for this type of imaging study. If you or your child is a cancer patient aged 18 years or older, you may be eligible to participate. Participants will undergo a PET/CT scan, which is a special imaging test that helps doctors see how the body is functioning. It's important to note that patients who are severely ill or have very low blood sugar levels will not be included in the study. This research aims to improve the understanding of how PET scans work in children with cancer, ultimately leading to better care and treatment options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All Pediatric Cancer patients referred to nuclear medicine unit to do 18F-FDG PET/CT study.
- • All patients \> or = 18 years.
- Exclusion Criteria:
- • Severely ill patients. Patients with glucose level \< 200 mg/dl.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported